Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $4.56M | $0.00 | -$29.63M | -$35.65M | -$7.97 | N/A | -100.00% | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $18.94M | $0.00 | -$17.74M | -$18.50M | -$0.48 | N/A | N/A | N/A | N/A | 2025-11-18 | ||
| IMA | IMAGENEBIO INC | $91.30M | $0.00 | -$44.09M | -$46.14M | -$7.99 | -100.00% | N/A | N/A | N/A | |||
| CANF | CAN-FITE BIOPHARMA LTD | $4.40M | $560.00k | -$8.74M | -$8.80M | $0.00 | -16.04% | -20.34% | N/A | N/A | |||
| ATYR | ATYR PHARMA INC | $73.78M | $190.00k | -$73.96M | -$75.12M | -$0.82 | -19.15% | -53.29% | N/A | N/A | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $35.65M | $752.00k | -$51.29M | -$68.21M | -$9.04 | -66.96% | N/A | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $69.96M | $242.00k | -$38.02M | -$38.06M | -$2.36 | N/A | N/A | N/A | N/A | |||
| SGMO | SANGAMO THERAPEUTICS INC | $149.74M | $32.88M | -$101.50M | -$108.91M | -$0.45 | -37.13% | -25.91% | N/A | N/A | |||
| PSTV | PLUS THERAPEUTICS INC | $70.09M | $5.26M | -$16.33M | -$20.58M | -$1.70 | -8.16% | 28.67% | N/A | N/A | |||
| TVRD | TVARDI THERAPEUTICS INC | $37.81M | $4.02M | -$8.73M | -$13.95M | -$8.50 | -21.70% | -31.91% | N/A | N/A | |||
| GRI | GRI BIO INC | $5.52M | $0.00 | -$11.25M | -$13.16M | $14.40 | N/A | N/A | -99.41% | N/A | |||
| ACET | ADICET BIO INC | $101.46M | $0.00 | -$105.29M | -$115.01M | -$1.25 | N/A | -100.00% | N/A | N/A | |||
| KRRO | KORRO BIO INC | $57.16M | $7.37M | -$82.74M | -$88.42M | -$9.41 | N/A | -25.32% | N/A | N/A | |||
| SKYE | SKYE BIOSCIENCE INC | $41.67M | $0.00 | -$50.55M | -$51.23M | -$1.29 | N/A | N/A | N/A | N/A | |||
| CING | CINGULATE INC | $23.58M | $0.00 | -$21.49M | -$22.06M | -$3.62 | N/A | N/A | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $18.70M | $1.07M | -$19.03M | -$18.24M | -$2.13 | N/A | N/A | N/A | N/A | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $13.99M | $0.00 | -$7.95M | -$7.95M | -$2.15 | N/A | N/A | N/A | N/A | |||
| MTVA | METAVIA INC | $16.93M | $0.00 | -$16.20M | -$16.22M | -$1.08 | N/A | N/A | N/A | N/A | |||
| VNRX | VOLITIONRX LTD | $40.65M | $1.47M | -$21.14M | -$22.88M | -$0.23 | 14.48% | 197.53% | N/A | N/A | |||
| CYBN | CYBIN INC | $136.59M | $0.00 | -$70.85M | -$71.04M | -$3.20 | N/A | N/A | N/A | N/A | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.07M | $0.00 | -$14.51M | -$12.70M | -$0.55 | N/A | N/A | N/A | N/A | 2025-12-01 | ||
| RNXT | RENOVORX INC | $27.49M | $928.00k | -$11.42M | -$11.11M | -$0.36 | N/A | N/A | N/A | N/A | 2025-11-17 | ||
| ZYXI | ZYNEX INC | $17.27M | $144.81M | -$16.64M | -$28.66M | -$0.94 | -25.21% | 19.08% | N/A | N/A | |||
| MYO | MYOMO INC | $31.36M | $41.64M | -$9.73M | -$12.02M | -$0.28 | 64.99% | 50.95% | N/A | N/A | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $8.77M | $5.20M | -$39.41M | -$42.68M | -$22.18 | -46.88% | 77.36% | N/A | N/A | |||
| MBRX | MOLECULIN BIOTECH INC | $22.10M | $0.00 | -$41.25M | -$41.36M | -$1.35 | N/A | N/A | N/A | N/A | |||
| AVXL | ANAVEX LIFE SCIENCES CORP | $313.08M | $0.00 | -$48.29M | -$48.17M | -$0.57 | N/A | N/A | N/A | N/A | 2025-12-22 | ||
| SLN | SILENCE THERAPEUTICS PLC | $322.29M | $26.10M | -$67.75M | -$66.59M | N/A | 27.31% | N/A | N/A | N/A | |||
| TIL | INSTIL BIO INC | $97.80M | $0.00 | -$66.30M | -$75.08M | -$11.39 | N/A | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $41.45M | $34.35M | -$8.52M | -$10.59M | -$0.18 | 15.09% | -1.19% | N/A | N/A | |||
| NAKA | KINDLY MD INC | $4.67M | $2.24M | -$5.19M | -$5.47M | -$0.86 | -27.67% | N/A | N/A | N/A | 2025-12-03 | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $10.10M | $0.00 | -$22.12M | -$24.14M | -$19.13 | N/A | N/A | N/A | N/A | |||
| IMUX | IMMUNIC INC | $93.70M | $0.00 | -$102.73M | -$103.05M | -$0.83 | N/A | N/A | N/A | N/A | |||
| IFRX | INFLARX NV | $91.46M | $73.07k | -$46.08M | -$46.63M | -$0.70 | -60.51% | N/A | N/A | N/A | |||
| ATOS | ATOSSA THERAPEUTICS INC | $103.34M | $0.00 | -$30.16M | -$30.18M | -$0.24 | N/A | N/A | N/A | N/A | 2025-11-17 | ||
| HUMA | HUMACYTE INC | $230.34M | $1.57M | -$18.88M | -$36.97M | -$0.23 | N/A | N/A | N/A | N/A | |||
| JSPR | JASPER THERAPEUTICS INC | $47.01M | $0.00 | -$89.05M | -$91.02M | -$5.92 | N/A | N/A | N/A | N/A | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $57.76M | $0.00 | -$22.71M | -$22.76M | -$0.46 | N/A | N/A | N/A | N/A | 2025-11-17 | ||
| CABA | CABALETTA BIO INC | $222.37M | $0.00 | -$145.48M | -$158.52M | -$2.53 | N/A | N/A | N/A | N/A | |||
| BMEA | BIOMEA FUSION INC | $90.50M | $0.00 | -$91.46M | -$95.71M | -$2.38 | N/A | N/A | N/A | N/A | |||
| AMTX | AEMETIS INC | $125.89M | $201.32M | -$46.68M | -$87.87M | -$1.56 | -30.91% | 2.23% | N/A | N/A | |||
| BNGO | BIONANO GENOMICS INC | $15.47M | $28.72M | -$27.91M | -$38.59M | -$12.86 | -13.84% | 31.50% | N/A | N/A | |||
| NKTX | NKARTA INC | $132.83M | $0.00 | -$91.40M | -$102.61M | -$1.37 | N/A | N/A | N/A | N/A | |||
| AKTX | AKARI THERAPEUTICS PLC | $37.81M | $0.00 | -$16.51M | -$15.77M | $0.00 | N/A | N/A | N/A | N/A | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $154.62M | $1.08M | -$104.81M | -$105.80M | -$1.50 | -30.96% | -35.66% | N/A | N/A | 2025-11-18 | ||
| SNTI | SENTI BIOSCIENCES INC | $42.33M | $0.00 | -$43.38M | -$47.58M | -$3.28 | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.